Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Fairmount Healthcare Fund Ii Gp Llc

Director at Viridian Therapeutics, Inc.\DE (VRDN)

Purchase track record

Not enough history. Based on 1 purchase with a full 90 days of price history.

—
Avg. 90-day return+46.7%
vs. S&P 500+45.3%
Beat the market100%
Paper profit on buys−$1.5M
Total bought / sold$10.0M / $0

Reported trades

Filed Stock Type Shares Price Value Since
Oct 27SEC VRDNViridian Therapeutics, Inc.\DE Buy 454,5453,914,458 held (+13%) $22.00 $10.0M -15.2%
  • Buy

    Director Fairmount Healthcare Fund Ii Gp Llc bought $10.0M of VRDN at $22.00 — first open-market purchase in our records.